United Therapeutics Chairperson, CEO Martine Rothblatt reports UTHR common share disposal worth $4.61 million

PUBT · 1d ago
United Therapeutics Chairperson, CEO Martine Rothblatt reports UTHR common share disposal worth $4.61 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 117.76 on Sept. 25, 2026.
  • The trust then sold 9,500 shares the same day in multiple trades at USD 470.5565 to USD 478.9522.
  • Trust holdings fell to 324,443 shares following the sales.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000150), on September 28, 2026, and is solely responsible for the information contained therein.